Quote For Bioniche Life Sciences Inc. BNC.TO
Bioniche Life Sciences Inc. (BNC.TO) (Toronto Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$0.41
27 Nov 2009
+0.00%
$0.41
$0.41
149,000
$0.41
$0.40
$0.75
$0.30
0.52
88,196
News
Press Releases
No news stories for this company within the last 30 days.
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| McRae, Graeme | Chairman of the Board, President, Chief Executive Officer | 377,549 |
| Ford, Brian | Chief Financial Officer | -- |
| Beraldo, Albert | Director; President of Alveda Pharmaceuticals Inc. | -- |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $29.50 |
| Shares Outstanding (Mil.) | 71.96 |
| Float (Mil.) | 63.60 |
| Dividend Information | |
|---|---|
| Yield % | -- |
| Annual Dividend ($ CAD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 0.66 |
| Current Ratio | 0.97 |
| LT Debt/Equity | 26.08 |
| Total Debt/Equity | 81.90 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 0.89 |
| Price/Book(TTM) | 203.98 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-0.15 |
| Sales(TTM) | $0.47 |
| Book Value(MRQ) | $0.13 |
| Cash Flow(TTM) | $-0.12 |
| Cash(MRQ) | $0.08 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -276.22 |
| Return on Assets(TTM) | -30.32 |
| Return on Investment(TTM) | -51.97 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 56.64 |
| Operating Margin(TTM) % | -30.61 |
| Profit Margin(TTM) % | -31.56 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
